Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Curtis Lockshin currently holds 35,155 shares of Phio Pharmaceuticals Corp. (PHIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Curtis Lockshin has been a net buyer of PHIO stock. They have purchased $3.7K and sold $0 worth of shares.
Curtis Lockshin's most recent insider trade was on Feb 5, 2026, when they sold 16,600 shares at $0.00 per share.
Curtis Lockshin serves as Executive at Phio Pharmaceuticals Corp. (PHIO). They have executed 10 insider transactions totaling $3.7K over their tenure at the company.
Curtis Lockshin holds the position of Executive at Phio Pharmaceuticals Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Curtis Lockshin has shown a buying trading pattern, with $3.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Curtis Lockshin was on Jun 2, 2015, when they purchased $4.8K worth of RXII shares. This transaction involved 12,000 shares at $0.40 per share.
Curtis Lockshin currently owns 35,155 shares of Phio Pharmaceuticals Corp. (PHIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Curtis Lockshin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Curtis Lockshin has 10 Form 4 filings on record as an insider at Phio Pharmaceuticals Corp..
Set alerts for Curtis Lockshin and 40,000+ other insiders.